Skip to main content

Advertisement

Table 2 Treatment methods for the enrolled patients

From: Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis

  WBRT (n = 26) non-WBRT (n = 25)
WBRT alone 3 0
EGFR-TKIs alone 0 9
ChT alone 0 9
WBRT+EGFR-TKIs 20 0
WBRT+ChT 3 0
EGFR-TKIs+ChT 0 7
  1. EGFR Epidermal growth factor receptor, TKI Tyrosine kinase inhibitor, ChT Chemotherapy, WBRT Whole brain radiotherapy